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Abstract 
The study of peripheral nerve repair and regeneration is particularly relevant in the light of 
the high clinical incidence of nerve lesions. Yet, clinical outcome after nerve lesions is often far 
from being satisfactory and the functional recovery is almost never complete. Therefore, a 
number of therapeutic approaches are being investigated, ranging from local delivery of trophic 
factors and other molecules to bioactive biomaterials and complex nerve prostheses. Although the 
translation of the new therapeutic approaches to the patients always requires a final pre-clinical 
step using in vivo animal models. The need to limit as much as possible animal use in biomedical 
research, however, makes the preliminary use of in vitro models mandatory from an ethical point 
of view. 
In this paper, the different types of in vitro models available today for the study of 
peripheral nerve regeneration have been ranked adopting a three-step stair model based on their 
increasing ethical impact: 1) cell line-based models, that raise no ethical concern; 2) primary cell-
based models, that have low ethical impact since animal use, though necessary, is limited; 3) 
organotypic ex vivo-based models, that raise moderate ethical concerns since the use of 
laboratory animals is required though with much lower impact on animal wellbeing in comparison 
to in vivo models of peripheral nerve regeneration. 
This paper aims to help researchers in selecting the best experimental approach for their 
scientific goals being driven by the ‘‘Three Rs’’ rules (Replacement, Reduction or Refinement of 
animal use in research) for scientific research. 
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1. Introduction  
Peripheral nerve regeneration after injury is a very complex phenomenon that involves a 
number of changes at molecular, cellular, and tissue level (Tetzlaff, Alexander et al. 1991, Navarro, 
Verdu et al. 1994, Fornaro, Lee et al. 2008, Geuna, Tos et al. 2009, Camara-Lemarroy, Guzman-de 
la Garza et al. 2010). Biological changes are even more dramatic when severe nerve lesions cause 
a nerve tissue defect since, in cases where autologous nerve grafting is no option, an artificial 
nerve scaffold (nerve prosthesis) is required to bridge the nerve gap and reestablish the 
connection with the distal targets (Dahlin and Lundborg 2001, Battiston, Papalia et al. 2009, 
Deumens, Bozkurt et al. 2010, Gonzalez-Perez, Cobianchi et al. 2014). 
A number of strategies are presently being investigated with the goal of designing 
innovative tissue engineered devices which improve peripheral nerve repair and regeneration. 
These include among others: (1) the systemic administration of neuroprotective drugs; (2) the 
controlled local release of neurotropic factors and/or other neuroactive cytokines; (3) the 
production of biomimetic materials which mimic the properties of the peripheral nerve 
environment; (4) the surface functionalization of nerve scaffolds with bioactive molecules; (5) the 
local stimulation by means of pro-regenerative physical agents. 
Several specific elements of the peripheral nerve regeneration processes can be effectively 
reproduced in vitro although the complexity of the peripheral nerve structure and the 
regeneration process are impossible to be entirely reproduced in vitro.. Nonetheless it is 
mandatory to respect the ‘‘Three Rs’’ (3Rs, Replacement, Reduction, Refinement ) principle in 
animal use in research (Tannenbaum and Bennett 2015) and researchers have been imposed to 
use in vitro models of peripheral nerve regeneration as intensive and effective as possible, before 
they proof their concepts in in vivo animal models (European Directive 2010/63/EU). 
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The aim of this review is to describe and classify in vitro models for the study of peripheral 
nerve regeneration by ranking them on a three-step stair model based on the degree of ethical 
concern they are raising. At the bottom stand1) cell line-based models (Fig.1A), for which no 
animal use is needed and which thus have no ethical impact. At the middle rank 2) primary cell-
based models (Fig.1B-C), that raise little ethical impact since animal use, though necessary, is 
usually limited. The final step build 3) organotypic ex vivo-based models (Fig.1D), for which the use 
of laboratory animals is unavoidable, but the impact on the animals wellbeing is much lower in 
comparison to in vivo models for peripheral nerve regeneration. Figure 2 provides a schematic 
overview of the relation between ethical concerns, costs and technical efforts, and the 
comparability to the complex in vivo model system. 
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2. Cell line-based models 
The great ethical advantage of cell lines is that once created from animal tissues, they 
completely replace any further animal sacrifice. In many cases they are even derived from human 
tissues and represent a positive feature in the perspective of translational research towards the 
clinic.. On the other hand it has to be strengthened that biological properties of cell lines are far 
away from those of the corresponding mammalian cells in normal conditions since cell lines are 
either derived from neoplastic tissue or from normal cells that have been immortalized through 
genetic manipulation. 
Related to these two features of cell lines, the following indications/contraindications for 
their use for peripheral nerve regeneration research can be specified. 
Indications 
Due to the lack of an ethical impact, the use of Schwann cell and nerve cell lines represent 
the first research step to acquire a body of preliminary data on several basic aspects including: 
(i) the signaling pathways activated by new molecules/drugs (Armstrong, Wiberg et al. 
2008, Magnaghi, Parducz et al. 2010, Gnavi, di Blasio et al. 2014, Pascal, Giovannelli et al. 2014),  
(ii) the biocompatibility of new and/or modified biomaterials (Gnavi, di Blasio et al. 
2014, Novajra, Tonda-Turo et al. 2014, Wrobel, Serra et al. 2014), 
(iii) the cell behavior changes due to environmental alterations induced by physical 
agents (magnetic fields, light radiations, mechanical forces, etc.) (Gamboa, Gutierrez et al. 2007, 
Koppes, Nordberg et al. 2014, Liu, Huang et al. 2015). 
Contraindications 
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Due to their profound differences compared to normal animal cells, cell lines cannot be 
used to predict the in vivo behavior of Schwann cells and neurons (unless they are used as models 
of neoplastic tissue). 
Within these limitations, some examples of Schwann cell and nerve cell lines have been 
selected based on the following criteria: a) overall reliability assessed on the basis of literature 
data; b) the firsthand experience on some of them in our own research laboratories. In the next 
paragraphs, these examples are described and grouped according to the two major actors in 
peripheral nerve regeneration: Schwann cells and neurons. 
 
2.1 Schwann cells 
Several models of immortalized cell lines of peripheral glial cells, Schwann cells, serve to 
study basic elements of peripheral nerve regeneration. 
RT4D6P2T (Imada and Sueoka 1978), JS-1 (Kimura, Fischer et al. 1990), RSC96 (Badache and 
De Vries 1998), R3(Ridley, Paterson et al. 1988), and S16Y (Toda, Small et al. 1994) cell lines are 
some of the most frequently used models of immortalized Schwann cells that are either obtained 
from tumors of nervous tissues or from genetic manipulation of glial precursors. In a comparative 
study, Hai and colleagues (Hai, Muja et al. 2002) have carefully explored that RT4-D6P2T represent 
the immortalized cell line with features most similar to primary Schwann cells. The RT4-D6P2T cell 
line maintains the expression of key genes that characterize Schwann cells, but still there are some 
differences to primary cells that have to be considered.  
Cell proliferation is a very important functional aspect of Schwann cells to be respected 
when studying peripheral nerve regeneration in vitro. The neoplastic RT4-D6P2T cell line makes 
evaluation of cell proliferation very easy since it provides a homogeneous population, free of 
cellular senescence which researcher may encounter very early when using primary Schwann cells 
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cultures. Therefore, RT4-D6P2T cells have been found to be a useful model in assessing scaffold 
materials for peripheral nerve guide such as, e.g., a VEGF (vascular endothelial growth factor)-
functionalized hydrogel (Gnavi, di Blasio et al. 2014), polycaprolactone/chitosan nanofibers 
(Prabhakaran, Venugopal et al. 2008), various types of electrospun fibrous substrates  (Sangsanoh, 
Waleetorncheepsawat et al. 2007), or amorphous carbon substrates with varying surface texture 
sensitivity (Jain, Sharma et al. 2013). Moreover RT4-D6P2T cells can be easily transfected to induce 
over-expression of neurotrophic factors or release of other substances/drugs. As such they are  
particularly suitable for the evaluation of enriched and functionalized scaffolds for peripheral 
nerve regeneration (de Guzman, Ereifej et al. 2008). 
On the other hand, the expression of the Neuregulin1/ErbB system that characterizes 
Schwann cell precursor growth and the interactions between Schwann cells (expressing ErbB2-
ErbB3 and soluble type I/II NRG1) and axons (mainly expressing transmembrane NRG1-type III), for 
example, has been found to be different between primary Schwann cells and RT4-D6P2T cells, as 
the latter do not express NRG1 type I/II (Pascal, Giovannelli et al. 2014). 
Schwann cells, however, are not the only suitable glial cell model for research on 
peripheral nerve regenerative processes. The neonatal olfactory bulb ensheathing cell (NOBEC) 
line was obtained from dissociated rat neonatal olfactory bulbs  and immortalization of the  
primary cells by retroviral transduction of the SV40 large T antigen (Goodman, Silver et al. 1993). 
These versatile cells, similar to both Schwann cells and the central nervous astroglia , can be used 
in a wide range of experiments related to both central nervous system and peripheral nervous 
system regeneration . When characterizing  the NOBEC cell line morphological, molecular, and 
migratory properties , Audisio and colleagues found homogeneity in the expression of markers 
typical for Schwann cells, as well as the expression of the NRG1 / ErbB system, as a key element in 
regeneration and myelination of peripheral nerves (Audisio, Raimondo et al. 2009, Gambarotta, 
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Ronchi et al. 2014). Consequently, the NOBEC line represents another useful model to determine 
the ability of innovative biomaterials for peripheral nerve repair to induce cell alignment (Chiono, 
Sartori et al. 2011, Novajra, Tonda-Turo et al. 2014). 
 
 
2.2 Neuronal cells  
In vitro studies using the peripheral nervous system related neuronal population are even 
more complex than those using glial cells. Primary neuron cultures cannot survive for considerable 
period of time in the absence of a permissive environment which is  represented by 
heterogeneous populations of cells, including glial cells and fibroblasts. Therefore neuronal cell 
lines have to be used to screen substance and biomaterial effects on specific aspects of neuronal 
behavior.   
The PC12 cell line, for example, which is derived from rat phaeochromocytoma cells of 
sympathoadrenal origin, is available to screen th pro-regenerative potential of substances and 
biomaterials in neurite outgrowth assays (Greene and Tischler 1976, Pittier, Sauthier et al. 2005, 
Morano, Wrobel et al. 2014). But it has to be strengthened, that although the PC12 cell line shows 
neurite extensions upon, e.g. neurotrophic factor stimulation, these cells are not closely related to 
sensory or motor neurons whose axons compose peripheral nerves. Especially with regard to 
molecular studies, where high amounts of cellular material are needed, cell lines generally provide 
optimal model systems. The cell lines chosen, however, have to share as much similarities with the 
primary cells as possible. In the following we describe two cell lines which could give more specific 
information in the context of peripheral nerve regeneration research than PC12 cells.  
An SV40-large T antigen transfected, immortalized, cell line of sensory neurons (50B11) has 
been generated from rat embryonic dorsal root ganglion (DRG) neurons and provides the 
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properties of nociceptive DRG neurons (Chen, Mi et al. 2007, Bhattacherjee, Liao et al. 2014). 
These cells remain largely undifferentiated under standard culture conditions, but upon a forskolin 
stimulus they assume neuronal properties such as neurite extension, neuronal marker expression, 
and action potential generation (Chen, Mi et al. 2007). The 50B11 cells further respond to trophic 
factor and hormone supplementation in a manner that is largely similar to DRG neurons used in 
neurite outgrowth assays (Bhattacherjee, Liao et al. 2013). Once differentiated, however, the cells 
do only survive for additional 72 hours and this limits their use to short term assays and makes 
them unsuitable for  e.g., in vitro myelination assays usually requiring culture times of more than 
10 days (Pittier, Sauthier et al. 2005, Blugeon, Le Crom et al. 2011) . 
The NSC-34 mouse motor neuron cell is a hybrid cell line derived from the fusion of mouse 
neuroblastoma cells and motor neuron-enriched spinal cord cells (Cashman, Durham et al. 1992). 
The NSC-34 cells maintained properties characteristic for motor neurons, including the generation 
of action potentials, expression of neurofilament triplet proteins, and acetylcholine synthesis, 
storage, and release. The use of NSC-34 cells is often selected for studies related to motor neuron 
degenerative diseases (Raimondi, Mangolini et al. 2006, Sun, Benardais et al. 2013). However, 
these cells offer the possibility to reveal basic mechanisms of motor neurite outgrowth (Madison, 
McGee et al. 2014) in an ethically uncritical, less cost intensive, and technically much easier 
culture system than primary or organotypic systems provide. One example is the use of NSC-34 
cellsin combination with C2C12 muscle cell line to investigate the benefits derived from the use of 
extracellular vesicles from muscle cells for peripheral nerve regeneration (Madison, McGee et al. 
2014).  
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3. Primary cell-based models 
 
The use of cell lines in order to answer complex questions related to peripheral nerve 
regeneration processes has obviously a lower impact on the generality of study conclusions than 
the use of primary cell cultures. Unlike cell lines, primary cell cultures are composed of naive cells, 
i.e. Schwann cells and neurons harvested from healthy animal tissues. Consquently, in vitro 
experiments using primary cells are suitable to more closely reproduce what happens in vivo in 
the peripheral nerve. It should be noted however, that the harvest of neurons (both sensory and 
motor) requires the unavoidable transection of their axons and the loss of contact with their 
target organs, thus making it practically impossible to set-up primary cultures of uninjured 
neurons. The same is true for Schwann cells when they are isolated from axons. More properly, 
we have to admit that primary cultures mimic a condition in which the normal physiological 
properties of Schwann cells and neurons are subjected to an axonal trauma. In this view, these cell 
cultures adequately reproduce what happens to Schwann cells and neurons after peripheral nerve 
injury. 
Therefore, the data obtained from these in vitro models are more likely to predict the 
phenomena occurring in vivo during nerve regeneration than cell-line based models. But, primary 
peripheral nerve cell cultures have also a main drawback represented by the complete destruction 
of the 3D tissue framework during the dissociation procedure. The 3D tissue framework , 
especially in the nervous system, is extremely complex and has a high impact on cellular functions. 
This dramatic environmental modification is thus likely to induce profound changes in the 
dissociated cells, and should be kept in mind when interpreting the results obtained from these in 
vitro models. 
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Related to the features of primary peripheral nerve cell cultures described above, the 
following indications/contraindications for their use as in vitro models for peripheral nerve 
regeneration research can be specified. 
Indications 
Due to the ethical concern that arises from the use of animals in research, although usually 
limited, primary cells (both of Schwann cells and neurons) should be regarded as the second 
research step to acquire information not obtainable by using cell lines; this includes data on: 
(i) the signaling pathways specifically induced by various molecules/drugs on Schwann 
cells and/or neurons (Shin, Jang et al. 2013, Schmid, Zeis et al. 2014); 
(ii) the proliferation and/or apoptosis activation induced by different types of chemical 
and physical stimuli (Pellitteri, Catania et al. 2014); 
(iii) the biomimetic properties of biomaterials, i.e. how closely they reproduce the 
effects of the natural nerve environment on Schwann cells or neurons (Ribeiro-Resende, Koenig et 
al. 2009, Haastert-Talini, Geuna et al. 2013); 
(iv) the specific changes in Schwann cell and/or neuronal behavior upon single or 
multiple stimuli (e.g. trophic factor administration, plus biostimulation by physical agents, plus 
surface functionalization of biomaterials) (Brushart, Aspalter et al. 2013, van Neerven, Pannaye et 
al. 2013, Morano, Wrobel et al. 2014); 
(v) the neuron-glial differentiation potential of stem cells (de Luca, Faroni et al. 2015) 
 
Contraindications 
Due to the changes that might have been induced by cell dissociation, data obtained from 
primary cell cultures might not fully predict what happens at the whole organ level and thus, 
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especially prior to concluding about potential clinical implications these data should be always 
verified in in vivo models.  
Within these limitations, in the next paragraphs we will describe the most frequently used 
types of primary cell cultures for peripheral nerve regeneration research. These include two types 
of Schwann cells (Schwann cells strictu senso, i.e. those dissociated from peripheral nerves, and 
glial cells harvested from the olfactory nerve, that are commonly referred to as olfactory 
ensheating cells) as well as two types of neurons (sensory neurons isolated from dorsal root 
ganglia (DRGs) and spinal motor neurons).  
 
 
3.1 Schwann cells 
 
Primary cultures of Schwann cells can be obtained from nerves of neonatal and adult rats, 
mice, dog and human (Haastert-Talini 2012, Tao 2013). They retain similar features compared to 
Schwann cells in vivo. Unfortunately, in culture they have a limited life span (usually at passage 10 
they lose their typical bipolar shape and become multipolar as sign of senescence). The removal of 
contaminating fibroblasts, however, is difficult because these cells proliferate faster than Schwann 
cells. The first important step to minimize the amount of fibroblasts in the culture is the removal 
of the epineurium immediately after nerve harvest. Then different strategies can be followed to 
further reduce the presence of fibroblasts in the culture.  
Commonly, the supplementation of Ara-C (cytosine-B-arabinoside hydrochloride), an anti-
mitotic agent, to the culture medium for 24h is used to eliminate most of the fibroblasts growing 
among Schwann cells (Wei, Zhou et al. 2009). Antibody-mediated immunoselection is also a 
commonly used procedure to highly enrich Schwann cell cultures (van Neerven, Pannaye et al. 
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2013, Wrobel, Serra et al. 2014). Kaewkhaw and colleagues described a protocol that exploits the 
preferential capacity of adult rat Schwann cells to metabolize D-valine and the elimination of 
fibroblasts by using selective culture conditions (Kaewkhaw, Scutt et al. 2012).  
Cultures of adult human Schwann cells are a precious source for pre-clinical in vitro studies. 
These cells can either be obtained from cauda equina donors a few hours after death (Tapinos and 
Rambukkana 2005) or from sural nerve specimen of patients undergoing an autologous nerve 
graft surgery (Haastert, Mauritz et al. 2007). Purification of adult human Schwann cell cultures can 
be obtained by differential detachment which washes the Schwann cells out of the initially 
fibroblast contaminated cultures. In combination with selective culture conditions highly purified 
adult human Schwann cell cultures could be maintained (Haastert, Mauritz et al. 2006, van 
Neerven, Pannaye et al. 2013).  
Olfactory ensheating cells (OECs) share the expression of several specific markers such as S-
100 and low-affinity nerve growth factor receptor (p75) with Schwann cells (Guerout, Derambure 
et al. 2010, Honore, Le Corre et al. 2012, Pascal, Giovannelli et al. 2014). These cells are of 
particular interest for their ability to promote remyelination of damaged axons both in the central 
nervous system  (Boyd, Doucette et al. 2005) and the peripheral nervpus system (Guerout, Paviot 
et al. , Guerout, Paviot et al. 2014).  
 
3.2 Neuronal cells 
Neuronal survival, neurite elongation, orientation and branching, differentiation, and basic 
mechanisms of the neuronal physiology are parameters to be studied in order to understand the 
response of neurons to substance/drug administration and/or to interaction with biomaterials in 
vitro. 
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Dissociated primary neurons from adult, neonatal or embryonic DRG or spinal cord can be 
used to test the behavior of sensory and motor neurons, respectively, but the purification of these 
cultures is demanding (especially in case of spinal cord motor neurons).  
A dissociated DRG neuron culture can be co-cultured with different Schwann-like derived 
stem cells, providing a valuable model to study nerve regeneration and myelination in vitro, 
mimicking the in vivo environment at the injury site (de Luca, Faroni et al. 2015). 
The culture of dissociated or isolated neurons, allows the in depth study of factors that are 
able to modulate neuronal behavior, e.g. the involvement of aquaporin-1 in axonal growth and 
regeneration (Zhang and Verkman 2015).  
On the other hand, the presence of Schwann cells in neuronal cultures represents an 
obstacle beause these cells continue to proliferate and thus limit the possibility to discriminate the 
selective neuronal response to any given stimulus. Recently, Zuchero described an 
immunopanning-based method for rapid purification in the absence of antimitotic agents and 
serum (Zuchero 2014), by binding a selected cell population via an antigen-antibody reaction to a 
solid surface.. These Schwann cell free DRG neuron cultures are useful to study the role of glia in 
the biology of DRG neurons or if a growth factor has a direct or indirect effect on neurons. 
Embryonic  spinal cord motor neurons have been also successfully cultured (Graber and 
Harris 2013), although they represent  a minor population of developing spinal cord cells and have 
to be carefully purified and enriched to separate them from non-neuronal cells and other neurons 
(Haastert, Grosskreutz et al. 2005, Klausmeyer, Stern et al. 2015). 
The culture of adult motor neurons is still difficult due to their short-term survival, and 
limited axonal outgrowth. To date many researchers suggest different reproducible protocols to 
obtain long-term cultures of healthy and functional adult motor neurons (Milligan and Gifondorwa 
2011, Montoya-Gacharna, Sutachan et al. 2012). The culture of dissociated neurons allows 
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standardizing evaluation parameters, such as the number of cells that cannot be quantified in 
organotypic cell culture models.  
 
3.3 Induced pluripotent stem cells 
A final mention deserves the potential of the employment of induced pluripotent stem (iPS) cells 
of human origin (Robinton and Daley 2012). The possibility to convert human iPS into both 
neurons (Chambers, Qi et al. 2012) and Schwann cells (Liu, Swistowski et al. 2014) may open new 
ways in peripheral nerve regeneration related research and for the translation of research results 
into the clinical application. It can be foreseen that, once the differentiation technology has been 
optimized to reliable standards, iPS-derived human peripheral nervous system neurons and glial 
cells could become a powerful tool for primary cell culture in vitro models evaluating peripheral 
nerve regeneration both in single- and co-culture conditions. 
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4. Organotypic ex vivo-based models 
Organotypic cultures refer to in vitro culturing conditions which mimic the 3D organization 
of a tissue and/or organ. Therefore, contrary to in vitro models based on dissociated cells, 
organotypic cultures do not completely abolish the numerous chemico-physical environmental 
stimuli that contribute to the regulation of Schwann cell and neuron functions in vivo. 
From an ethical point of view, organotypic cell culture models still contribute to the 
reduction of the number of animals used for research purposes and they avoid animal discomfort 
occurring during the postoperative interval of in vivo experiments. The main drawback of 
organotypic cultures, when compared to in vivo models of peripheral nerve regeneration, is 
represented by the limited time window they provide for the observation of regeneration-related 
changes since the cultures can obviously not be maintained for months and resemble 
reconnection to target tissues. 
These features of organotypic cultures make it possible to specify the following 
indications/contraindications for their use in peripheral nerve regeneration research. 
 
Indications 
Organotypic cultures represent the third (and last) research step in the in vitro peripheral 
nerve regeneration research. In particular, they can be a good alternative to in vivo models when 
early (up to one month) changes under given experimental conditions are sought. These include 
collection of data on: 
(i) axon elongation, branching and orientation influenced by of different molecules, 
such as neurotrophic factors or biomaterials (Vyas, Li et al. 2010, Allodi, Guzman-Lenis et al. 2011, 
Gerardo-Nava, Hodde et al. 2014, Morano, Wrobel et al. 2014); 
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(ii) the onset of the myelination process which represents a key factor of nerve 
regeneration in the perspective of functional recovery in vivo (Levy, Garcia Segura et al. 1996, 
Triolo, Dina et al. 2012, Ziv-Polat, Shahar et al. 2014). 
Contraindications 
Although the 3D tissue environment is preserved, culture conditions cannot completely 
reproduce the normal tissue/organ environment (for instance the numerous circulating factors 
coming from the peripheral blood are lost in organotypic explants). In addition, the process of 
tissue explantation is itself traumatic and likely to induce biological changes in Schwann cells and 
neurons. Yet, as already mentioned, the observation window is limited in time to a maximum of 
few weeks in vitro. Finally, due to the complexity of organotypic models  their set-up has a higher 
ethical impact than the harvest of primary cell cultures, because the number of animals that need 
to sacrificed is much higher . 
Within these limitations, in the next paragraphs we will describe some of the commonly 
used organotypic culture models obtained either by 3D co-culturing of different cell components 
in presence of scaffolds mimicing the spatial organization of the tissue/organ, or by ex vivo 
explants. 
 
4.1 3D co-cultures 
 
While 2D co-cultures of neurons and glial cells do not reflect the 3D environment and the 
related complex cellular inetractions given in vivo, 3D co-cultures can be realized using complex 
matrices (Bozkurt, Brook et al. 2007, Gingras, Beaulieu et al. 2008) that mimic the 3D organization 
of a peripheral nerve during its regeneration. Bozkurt and colleagues developed a 3D, highly 
oriented, scaffold of cross-linked porcine collagen to promote directed axonal growth. 
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Furthermore, the microstructural properties of the scaffold allowed Schwann cells from explanted 
DRGs to migrate along the columnar structure of the scaffolds, and to thus resemble the "Bands of 
Büngner" (Bozkurt, Brook et al. 2007). 
Gingras and colleagues developed and characterized a 3D in vitro model of motor nerve 
regeneration by culturing  fibroblasts, Schwann cells, and spinal cord motor neurons on a collagen-
chitosan sponge (Gingras, Beaulieu et al. 2008). This in vitro model allowed the long-term survival 
of motor neurons and the elongation and myelination of their neurites through a 3D construct.  
Kraus and colleagues recently established from, the very simple hanging drop technique, a 
spheroidal sprouting assay (Kraus, Boyle et al. 2015). Spheroids of Schwann cells and neuronal 
NG108-15 cells (neuroblastoma-glioma hybrid cell line), were resuspended in a solution containing 
20% FCS and a collagen mix in order to create a 3D collagen matrix. Axonal sprouts in this 3D 
culture significantly increased in lenght and caliber over time in comparison to the  normal 2D co-
culture.This simple 3D-Schwann cell-neuron spheroid model enables multiplication of cell-cell 
physical interactions and to study more efficiently neurite development in vitro. 
 
4.2 Ex vivo explants 
 
The far most used ex vivo approach for preparing peripheral nervous system organotypic 
cultures is the DRG explant (Morano, Wrobel et al. 2014). The explants can be either obtained 
from embryonic (Liu, Gao et al. 2011), postnatal (Richardson, Rementer et al. 2011), or adult DRGs 
(Fornaro, Lee et al. 2008). Embryonic, postnatal, and adult DRG explants provide a different 
growth behavior, but all of these models can be used to study substances meant to induce less 
branching and more elongated and oriented axons, which represent preferential conditions for 
efficient in vivo peripheral nerve regeneration. A quantitative evaluation of axonal elongation and 
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branching can be performed with different methods (Tse, Chan et al. 2007, Morano, Wrobel et al. 
2014), including line intersection and point counting stereological tools (Gundersen, Bendtsen et 
al. 1988).  DRG explants contain also glial cells that, if properly stimulated, can migrate out of the 
explants and start myelination of regenerating axons (Ziv-Polat, Shahar et al. 2014). 
While DRG explants are a relatively simple and effective model for investigating axon 
regeneration and myelination in vitro, their main limitation is that they only offer insights on the 
behavior of sensory neurons. In order to study ex vivo the motor compartment of peripheral 
nerves, spinal cord explants can also be obtained, although using procedures that have a much 
higher degree of technical complexity (Fabbro, Villari et al. 2012, Pinkernelle, Fansa et al. 2013).   
Moreover spinal cord slice cultures have a limited basal outgrowth if compared to the 
growth capacity of DRG explants, for that reason they require longer time of culture (Allodi, 
Guzman-Lenis et al. 2011) 
Vyas and colleagues have developed a more advanced in vitro organotypic co-culture 
system (Vyas, Li et al. 2010), later also used by other authors (Gerardo-Nava, Hodde et al. 2014), 
that accurately models peripheral nerve repair in the adult mammal. This model is based on entire 
spinal cord explants with reconstructed ventral nerve roots. This organotypic culture, although 
technically very challenging, allows to test a full nerve scaffold (the entire nerve prosthesis) in vitro 
because the presence of a nerve pedicle, to which the nerve prosthesis can be sutured, 
reproduces the condition obtainable in vivo to a high degree. 
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5. Discussion 
 
Driven by the concurring growth of interest in tissue engineering and regenerative 
medicine, the interest in in vitro models to study peripheral nerve repair and regeneration has 
continuously increased over the last years (Geuna, Gnavi et al. 2013, Salgado and Gimble 2013). In 
this paper we have described and classified in vitro models for the study of peripheral nerve 
regeneration outlining their potential as well as their limitations. Table I summarizes the pros and 
cons of each model described. 
Besides their intrinsic scientific value for selected research purposes, in vitro models of 
peripheral nerve regeneration are more acceptable from an ethical point of view than in vivo 
models. In fact, the European Community (similar to many countries) has adopted a policy 
regarding the use of animals for scientific purposes that is driven by the ethically-oriented 3Rs 
concept of animal use in research (Tannenbaum and Bennett 2015). The three principles that 
underline the 3Rs concept are: 
 
(1) Replacement, i.e. the preferential adoption whenever possible of non-animal methods 
to achieve a scientific aim. 
(2) Reduction, i.e. the preferential adoption of methods that enable to obtain comparable 
information from fewer animals or more information from the same number of animals. 
(3) Refinement, i.e. the preferential adoption of methods that alleviate or minimize the 
impact on animal wellbeing and/or enhance animal welfare for those animals that cannot be 
replaced. 
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Figure 2 shows how the three-step stair model that we have adopted to rank the in vitro 
models of peripheral nerve regeneration exactly copes with the three principles of the 3Rs 
concept that, similarly, can be ranked on three levels on the basis of the degree of ethical concern 
that they raise. 
 
(1) The Replacement rule, which raises the lower ethical concern, is fulfilled by cell line-
based models that completely replace animal use. 
(2) The Reduction rule, which applies when animal use cannot be avoided completely, is 
fulfilled by primary cell-based models for which animal use is limited to sample harvest for cell 
isolation. 
(3) The Refinement rules, which applies when animal use can neither be avoided 
completely nor be reduced, is fulfilled by organotypic ex vivo-based models, that have very limited 
impact on animal wellbeing (only the distress of anesthesia before animal sacrifice), in comparison 
to in vivo models, where animals necessarily experience some degree of impairment along the 
postoperative observation period. 
 
From the indications/contraindications listed above for each of the described in vitro 
models it is obvious that the 3Rs policy can be fulfilled to a substantial degree in peripheral nerve 
regeneration research. Especially, when biocompatibility testing of innovative biomaterials for 
peripheral nerve repair is performed with selected cell lines related to the peripheral nervous 
system. Furthermore basic impacts of any treatment or biomaterial on Schwann cell migration and 
neurite outgrowth can sufficiently be tested in primary cell culture models. Organotypic culture 
models, although technically challenging can be used to replace short term in vivo experiments 
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and to finally select the most promising approaches to support peripheral nerve repair for pre-
clinical in vivo studies. 
Like in other fields of regenerative medicine research, however, those pre-clinical tests of 
innovative therapeutic approaches have to be done in specific in vivo models. Therefore, new 
therapeutic approaches for peripheral nerve repair and regeneration always need to be tested in 
animal models before their final translation to the patients. Examples from our own research 
attempts clearly demonstrate that approaches that proved to be very promising in vitro (e.g., a 
regenerative hydrogel) may completely fail to support (e.g., impair) peripheral nerve regeneration 
in vivo (Meyer, Wrobel et al. 2015). 
As in vivo research is unavoidable it is of highest importance to design comprehensive 
studies able to answer as many questions as possible with the minimal number of animals 
dedicated that still allows statistically relevant conclusions. This can usually be achieved by 
combinations of in vitro studies (after careful selection of relevant cell lines and primary cells) with 
well-designed in vivo studies investigating especially the functional and morphological outcome of 
the regenerative approach (Haastert-Talini, Geuna et al. 2013).  
 
6. Conclusions 
1) The use of in vivo models is unavoidable for the final pre-clinical testing of new 
strategies for improving peripheral nerve repair and regeneration. 
2) In vitro models, from simple and ethical concern-free models based on the use of cell 
lines up to technically and ethically more challenging organotypic models are a valuable tool for 
the preliminary screening of a number of elements before moving to long-term animal 
experiments. 
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3) The use of in vitro models enables a more limited and effective use of in vivo animal 
experiments, in accordance with the 3Rs policy, resulting in a much higher rate of success in the 
translation of basic biomedical research to the clinics. 
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Figure and table legend 
Figure 1: Immunofluorescent images of  neuronal cell line 50B011 (A), primary cultures of 
adult human Schwann cells (B), primary cultures of adult rat dissociated DRG neurons (C), adult rat 
organotypic DRG explant (D). Scale bars: 50 m (A,C); 200 m (B); 500 m (D). 
 
Figure 2: Scheme of in vitro models for the study of peripheral nerve regeneration, by 
ranking them on a three-step stair model based on the degree of ethical concerns, costs and 
technical efforts, and the similarity to the complex in vivo model system. 
 
Table I: Pros and Cons of the different in vitro models useful for peripheral nerve 
regeneration research. 
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